Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal OTC Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Laxatives
      • 1.4.3 Anti-Flatulents
      • 1.4.4 H2-Antaginists
      • 1.4.5 Anti-Diarrheals
      • 1.4.6 PPIs
      • 1.4.7 Anti-Emetics
      • 1.4.8 Other
    • 1.5 Market by Application
      • 1.5.1 Global Gastrointestinal OTC Drugs Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gastrointestinal OTC Drugs Market Size
    • 2.2 Gastrointestinal OTC Drugs Growth Trends by Regions
      • 2.2.1 Gastrointestinal OTC Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Gastrointestinal OTC Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gastrointestinal OTC Drugs Market Size by Manufacturers
      • 3.1.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gastrointestinal OTC Drugs Key Players Head office and Area Served
    • 3.3 Key Players Gastrointestinal OTC Drugs Product/Solution/Service
    • 3.4 Date of Enter into Gastrointestinal OTC Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gastrointestinal OTC Drugs Market Size by Type (2014-2019)
    • 4.2 Global Gastrointestinal OTC Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 5.2 Gastrointestinal OTC Drugs Key Players in United States
    • 5.3 United States Gastrointestinal OTC Drugs Market Size by Type
    • 5.4 United States Gastrointestinal OTC Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 6.2 Gastrointestinal OTC Drugs Key Players in Europe
    • 6.3 Europe Gastrointestinal OTC Drugs Market Size by Type
    • 6.4 Europe Gastrointestinal OTC Drugs Market Size by Application

    7 China

    • 7.1 China Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 7.2 Gastrointestinal OTC Drugs Key Players in China
    • 7.3 China Gastrointestinal OTC Drugs Market Size by Type
    • 7.4 China Gastrointestinal OTC Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 8.2 Gastrointestinal OTC Drugs Key Players in Japan
    • 8.3 Japan Gastrointestinal OTC Drugs Market Size by Type
    • 8.4 Japan Gastrointestinal OTC Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 9.2 Gastrointestinal OTC Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Gastrointestinal OTC Drugs Market Size by Type
    • 9.4 Southeast Asia Gastrointestinal OTC Drugs Market Size by Application

    10 India

    • 10.1 India Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 10.2 Gastrointestinal OTC Drugs Key Players in India
    • 10.3 India Gastrointestinal OTC Drugs Market Size by Type
    • 10.4 India Gastrointestinal OTC Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gastrointestinal OTC Drugs Market Size (2014-2019)
    • 11.2 Gastrointestinal OTC Drugs Key Players in Central & South America
    • 11.3 Central & South America Gastrointestinal OTC Drugs Market Size by Type
    • 11.4 Central & South America Gastrointestinal OTC Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline
      • 12.1.1 GlaxoSmithKline Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gastrointestinal OTC Drugs Introduction
      • 12.1.4 GlaxoSmithKline Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.1.5 GlaxoSmithKline Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gastrointestinal OTC Drugs Introduction
      • 12.2.4 Pfizer Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Johnson & Johnson
      • 12.3.1 Johnson & Johnson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gastrointestinal OTC Drugs Introduction
      • 12.3.4 Johnson & Johnson Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.3.5 Johnson & Johnson Recent Development
    • 12.4 Bayer
      • 12.4.1 Bayer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gastrointestinal OTC Drugs Introduction
      • 12.4.4 Bayer Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.4.5 Bayer Recent Development
    • 12.5 Procter & Gamble
      • 12.5.1 Procter & Gamble Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gastrointestinal OTC Drugs Introduction
      • 12.5.4 Procter & Gamble Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.5.5 Procter & Gamble Recent Development
    • 12.6 Perrigo
      • 12.6.1 Perrigo Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Gastrointestinal OTC Drugs Introduction
      • 12.6.4 Perrigo Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.6.5 Perrigo Recent Development
    • 12.7 Abbott
      • 12.7.1 Abbott Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Gastrointestinal OTC Drugs Introduction
      • 12.7.4 Abbott Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.7.5 Abbott Recent Development
    • 12.8 Sanofi
      • 12.8.1 Sanofi Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Gastrointestinal OTC Drugs Introduction
      • 12.8.4 Sanofi Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.8.5 Sanofi Recent Development
    • 12.9 Teva Pharmaceutical
      • 12.9.1 Teva Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Gastrointestinal OTC Drugs Introduction
      • 12.9.4 Teva Pharmaceutical Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.9.5 Teva Pharmaceutical Recent Development
    • 12.10 Nestle
      • 12.10.1 Nestle Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Gastrointestinal OTC Drugs Introduction
      • 12.10.4 Nestle Revenue in Gastrointestinal OTC Drugs Business (2014-2019)
      • 12.10.5 Nestle Recent Development
    • 12.11 Boehringer Ingelheim
    • 12.12 Reckitt Benckiser
    • 12.13 Purdue Pharma

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
      In 2018, the global Gastrointestinal OTC Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gastrointestinal OTC Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal OTC Drugs development in United States, Europe and China.

      The key players covered in this study
      GlaxoSmithKline
      Pfizer
      Johnson & Johnson
      Bayer
      Procter & Gamble
      Perrigo
      Abbott
      Sanofi
      Teva Pharmaceutical
      Nestle
      Boehringer Ingelheim
      Reckitt Benckiser
      Purdue Pharma

      Market segment by Type, the product can be split into
      Laxatives
      Anti-Flatulents
      H2-Antaginists
      Anti-Diarrheals
      PPIs
      Anti-Emetics
      Other

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gastrointestinal OTC Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Gastrointestinal OTC Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gastrointestinal OTC Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now